Evaluation of <scp>HER2</scp> expression in urothelial carcinoma cells as a biomarker for circulating tumor cells
Alessandro Nini(Düsseldorf University Hospital), Günter Niegisch(German Cancer Research Center)
Cited by 16
Related Papers
Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
|Targeted Oncology|2016|57
HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
|International Journal of Molecular Sciences|2019|19
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
|Journal of Experimental & Clinical Cancer Research|2014|1